Beike Biotech Preparation Center receives Computer Software Copyright from the National Copyright Administration!
On October 8, 2023, the cell bank team at the Beike Biotech Preparation Center's independently developed software system — the 'Cell Bank Sample……
CDE issues Guiding Principles: organoids may serve as efficacy and safety evaluation models for non-clinical research of human-derived stem cell products
In recent years, with the development of stem cell technology, deepened understanding, and accumulated experience, stem cell therapy has gradually become……
Beike Biotech Chairman Dr. Hu Junyuan interviewed by Shenzhen Commercial Daily: Medical AI is the biggest opportunity
Dr. Hu Junyuan, Chairman of Beike Biotech, interviewed in the Shenzhen Commercial Daily Innovation Salon, 11 November 2022. Reporter Wang Hairong.…
Supporting national standards! Beike Biotech participates in the official release of the GB/T 42398-2023 Technical Specification for the Design of Cell Culture Cleanrooms
On 17 March 2023, the State Administration for Market Regulation and the Standardization Administration of China issued China National Standard……
Building "Shenzhen Quality"! Dr. Hu Junyuan of Beike Biotech receives the "Shenzhen Quality-Driven City Gold Medal"
On 12 April 2023, the 2023 Shenzhen Quality-Driven City Promotion Conference and the 10th Anniversary Celebration of the Shenzhen Quality-Driven City……
Driving high-quality development of the cell industry: Beike Biotech wins the "Industry Pioneer Award"!
On 28 March 2023, the third change-of-leadership conference and 10th anniversary celebration of the Shenzhen Life Sciences……
Supporting national standards: the "Technical Code for the Design of Cell Culture Cleanrooms" national standard, in which Beike Biotech participated, has been officially released!
On 17 March 2023, the State Administration for Market Regulation and the Standardization Administration of China issued the No.…
Harbin Vice Party Secretary and Mayor Zhang Qixiang and his delegation visit Beike Biotech for inspection and exchange
On 20 March 2023, an 11-person delegation led by Zhang Qixiang, Vice Party Secretary and Mayor of Harbin, and Jiang Chuanhai, Standing Committee member of……
Beike Biotech donates RMB 500,000 to the Wang Zhengguo Trauma Medicine Development Foundation
Recently, Shenzhen Beike Biotechnology Co., Ltd. donated RMB 500,000 to the Wang Zhengguo Trauma Medicine Development Foundation, actively fulfilling its……
Research again recognized! Latest research from Beike Biotech's R&D team published in the international authoritative journal Cell Death & Disease
On 28 January 2023, Professor Cai Cheguo and Dr. Liao Yan's team at the R&D Center of Shenzhen Beike Biotechnology Co., Ltd.…
Vice President Wang Qiong of Taihe Hospital Wudangshan Branch and her delegation visit Beike Biotech for inspection and exchange
On 12 January 2023, a delegation including Wang Qiong, Vice President of Taihe Hospital Wudangshan Branch; Rao Jianwen, Chairman of Shiyan Wudang Zhidao……
Beike Biotech and Peking University Shenzhen Hospital collaborate on umbilical cord MSC therapy for type 2 diabetes; preliminary results released!
On 15 October 2022, the World Journal of Diabetes published the latest clinical research paper from Professor Zhang Fan and colleagues at the……